Pharmapacks Revenue, Valuation, Funding & Investors

Pharmapacks is valued at $1.1B as of November 2020, a 4.4x multiple on its last reported $250M revenue.

Last Pharmapacks valuation

$1.1B

Undisclosed stage · Nov 2020

Last Pharmapacks funding round

$250M

Undisclosed stage · Nov 2020

Pharmapacks revenue

$250M

Undisclosed stage · Nov 2020

Key investors in Pharmapacks

Pharmapacks Overview

About Pharmapacks

Pharmapacks is a New York-headquartered e-commerce platform specializing in logistics, fulfillment, marketing, and sales for health and beauty brands. Islandia-based since its founding in 2010 as a brick-and-mortar pharmacy, the company sells direct-to-consumer via Pharmapacks.com and through marketplaces like Amazon, Walmart.com, and eBay. It acts as a launchpad for emerging brands by integrating them into its proprietary tech platform and consumer base, handling end-to-end operations for over-the-counter products.


Founded

2010

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Revenue

$250M (Nov 2020)

Valuation

$1.1B (Nov 2020)

Pharmapacks Valuation

Pharmapacks is currently valued at $1.1B, based on its undisclosed-stage round in November 2020.

The $250M round was led by Carlyle Group, with participation from Reckitt Benckiser.

Pharmapacks valuation by funding round

Pharmapacks valuation by funding round
DateStageValuationRevenue Multiple
Nov 2020Undisclosed stage$1.1B4.4x

Pharmapacks Revenue

Pharmapacks' latest recorded revenue is $250M, as of its undisclosed-stage round in November 2020. At a $1.1B valuation, that implies a 4.4x revenue multiple.

Pharmapacks revenue by funding round

Pharmapacks revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Nov 2020$250M$1.1B4.4xUndisclosed stage

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Pharmapacks Funding History

Pharmapacks has raised a total of $473M across 4 funding rounds.

Pharmapacks' first fundraising round was a $33M Series A in June 2018. The most recent completed round was a $250M undisclosed-stage round in November 2020.

Pharmapacks funding rounds

Pharmapacks funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Nov 2020Undisclosed stageCarlyle Group (lead); Reckitt Benckiser$250M$1.1BPharmapacks, founded as a Bronx brick-and-mortar pharmacy, evolved into an ecommerce enablement platform and retail seller partnering with brands across marketplaces like Amazon, Walmart, eBay, Target, Google, and Facebook to provide logistics, fulfillment, marketing, and sales solutions. On November 12, 2020, it received a strategic growth investment of more than $250 million led by Carlyle Group from its Carlyle Partners VII fund, with Reckitt Benckiser also noted in the query context, valuing the company at approximately $1.1 billion enterprise value. J.P. Morgan acted as lender and advisor, while Cooley advised Pharmapacks legally. The investment aims to accelerate growth, including opening a 232,000-square-foot replenishment center in Edgewood as the main warehouse and distribution hub, expanding West Coast logistics, and entering categories like food and pet supplies. Pharmapacks had over 700 employees at the time, planning to hire 105 more for the new facility. CEO Andrew Vagenas highlighted Carlyle's resources to support the next growth phase. Financially, Pharmapacks achieved over $250 million in sales in 2019, with a current run rate for about 60% year-over-year growth in 2020, fueled by ecommerce demand. The company anticipates reaching $1 billion in sales within two years post-investment, leveraging its proprietary platform trusted by millions for daily needs.
Sep 2020Undisclosed stageReckitt Benckiser (lead); Sawaya Partners (lead); The Craftory (lead); The Emerson Group (lead); The Straus Group (lead)$40M-Pharmapacks is an e-commerce enablement platform and retail seller that connects brands to major online marketplaces including Amazon, Walmart, Google, eBay, and Facebook, handling logistics, fulfillment, marketing, and sales. Starting as a brick-and-mortar pharmacy in the Bronx, it has grown into one of North America's largest marketplace sellers with over 850 employees and proprietary technology serving millions of customers. The $40 million bridge round on September 3, 2020, was led by Reckitt Benckiser, The Craftory, The Straus Group, The Emerson Group, and Sawaya Capital Partners, following a July 2020 growth financing of $150 million from GPI Capital and JPMorgan Chase Bank. In 2019, Pharmapacks achieved over $250 million in sales and was on track for more than 70% year-over-year growth in 2020, supported by a new 230,000 square foot replenishment center opened in late Q3. This traction positioned it for potential 100% year-over-year growth in Q4 2020. The bridge financing aimed to support ongoing expansion amid strong e-commerce demand. This round fits into a series of fundraisings, including a prior $32.5 million round in 2018 led by Reckitt Benckiser with McKesson Ventures, Emerson Group, and Sealed Air. Two months later in November 2020, Pharmapacks secured over $250 million from The Carlyle Group at a $1.1 billion valuation, highlighting its rapid scaling in the third-party e-commerce fulfillment sector amid booming online retail.
Jul 2020Undisclosed stageGPI Capital (lead); JPMorgan Chase (lead); McKesson Ventures; The Emerson Group; Sealed Air; Reckitt Benckiser$150M-Pharmapacks is a US-based e-commerce enablement platform and third-party seller focused on health, beauty, wellness, and personal care products, providing end-to-end services including logistics, fulfillment, marketing, and sales across marketplaces like Amazon, eBay, Walmart, Google, and Facebook. Founded in 2010 as a Bronx pharmacy, it expanded with proprietary software for inventory management and partner integrations, serving major brands and sometimes taking ownership stakes. In July 2020, Pharmapacks secured up to $150 million in growth financing from GPI Capital and JPMorgan Chase (including a credit facility), with participation aligning with existing backers Reckitt Benckiser (RB), McKesson Ventures, Sealed Air, and The Emerson Group. The funds were earmarked for warehouse expansion, inventory investments, cost efficiencies, and partnership growth. This followed a $32.5 million Series A in mid-2018 led by RB. The company reported $250 million in sales (revenue) for 2019, with projections of 60-70% year-over-year growth in 2020, potentially reaching 100% in Q4 after opening a 230,000 square foot replenishment hub. a later November 2020 $250 million+ investment from Carlyle Group valued Pharmapacks at $1.1 billion post-money. Pharmapacks positioned itself as one of North America's largest marketplace sellers with 850 employees and strong e-commerce momentum amid rising online retail during the pandemic. Subsequent $40 million bridge financing in September 2020 was led by RB, The Craftory, Straus Group, Emerson Group, and Sawaya Capital.
Jun 2018Series AReckitt Benckiser (lead); McKesson Ventures; Sealed Air$33M-Pharmapacks is a US-based e-commerce fulfillment services provider specializing in health, beauty, and wellness sectors, serving online merchants on platforms like Amazon and eBay. In mid-2018, around June 12, Reckitt Benckiser led a $32.5 million Series A funding round, with participation from McKesson Ventures, Sealed Air, and Emerson Group. The company leveraged this capital alongside subsequent financings to fuel growth, including $150M debt from JPMorgan Chase and GPI Capital in July 2020, $40M bridge financing in September 2020 from Reckitt Benckiser and others, and a major $250M private equity investment from Carlyle Group in November 2020 at a $1.1 billion valuation. Pharmapacks pursued aggressive expansion, planning a 230,000 square foot replenishment hub with Carlyle funds, and in 2021 attempted a reverse merger with Packable via SPAC Highland Transcend Partners at a $1.55 billion enterprise value, supported by $180M PIPE from investors like Fidelity.

Who has invested in Pharmapacks?

10 investors have backed Pharmapacks across its funding rounds, including Reckitt Benckiser, McKesson Ventures, Sealed Air, The Emerson Group, Carlyle Group and JPMorgan Chase.

Lead investors include Carlyle Group, Reckitt Benckiser, Sawaya Partners, The Craftory, The Emerson Group and 3 other investors.


Pharmapacks Investors

Investors in Pharmapacks by funding rounds participated
InvestorHQRoundsRoleFirst check
Reckitt BenckiserBangladeshSlough4LeadJun 2018
McKesson VenturesUnited StatesSan Francisco, CA2ParticipantJun 2018
The Emerson GroupUnited StatesPhiladelphia, PA2LeadJul 2020
Sealed AirUnited StatesUnited States2ParticipantJun 2018
Sawaya PartnersUnited StatesNew York City, NY1LeadSep 2020
Carlyle GroupUnited StatesWashington, DC1LeadNov 2020
JPMorgan ChaseUnited StatesNew York City, NY1LeadJul 2020
GPI CapitalUnited StatesNew York City, NY1LeadJul 2020

This data is available for Pro users. Sign up to see all 10 Pharmapacks investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Investments by Pharmapacks

Pharmapacks has invested in 1 company to date.

Latest investment by Pharmapacks was on November 19th 2021. Pharmapacks invested in Amara Organic Foods in their $12M Series A round.


Latest Investments by Pharmapacks

Amara Organic Foods
Description
Amara Organic Foods produces organic baby and toddler meals using a patented steam-cooking process to retain nutrients in textured pouches for stages 4 months and up. San Francisco-headquartered since its 2012 founding, the company offers flavors like carrot parsnip ginger and mango black bean quinoa, available in major U.S. retailers such as Whole Foods and Target. Acquired by Hain Celestial Group in 2021, Amara expanded into kids snacks.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date19 Nov 2021
RoundSeries A
Raised$12M
InvestorsEat Well Investment Group; Liquid I.V; Spring St. Group
Valuation$100M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pharmapacks investments and their VC round multiples.

Start Free Trial

Pharmapacks Competitors

Pharmapacks competitors include listed companies like Hepsiburada and E-MART, and private ones like GlobalBees, Brands for Less, Oasis Market and HexClad.

Public and private companies comparable to Pharmapacks
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
GlobalBeesIndiaDelhiPrivate--$1.1B-
Brands for LessUAEDubaiPrivate--$1.2B-
Oasis MarketSouth KoreaSeongnamPrivate--$1B-
HexCladUnited StatesLos Angeles, CAPrivate--$1B-
HepsiburadaTurkeyTurkeyPublicly listed$1.7B($51M)$957M0.3x
E-MARTSouth KoreaSouth KoreaPublicly listed$21B$1.6B$1.4B0.5x

Pharmapacks Public Comps

Pharmapacks is still privately-owned, but its public comps include Chicmax Cosmetic, GoodRx, Cosmecca Korea, Moonpig Group, Tuhu Car, Hepsiburada, Jumia Technologies AG, Edgewell, Procter & Gamble Health and Mega Lifesciences.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Chicmax Cosmetic$1.4B$235M0.8x0.8x4.5x7.3x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
Cosmecca Korea$467M$71M2.5x2.1x16.5x12.9x
Moonpig Group$501M$140M2.3x2.3x8.2x8.2x
Tuhu Car$2.5B$84M0.3x0.2x7.6x7.8x
Hepsiburada$1.7B($51M)0.5x0.3x(15.8x)28.7x
Jumia Technologies AG$189M($51M)4.8x4.2x(17.8x)(26.4x)
Edgewell$2.2B$186M1.0x1.1x11.5x8.5x

This data is available for Pro users. Sign up to see all Pharmapacks competitors and their valuation data.

Start Free Trial

Common questions about Pharmapacks

When was Pharmapacks founded?Pharmapacks was founded in 2010.
Where is Pharmapacks headquartered?Pharmapacks is headquartered in New York City, NY, United States.
Is Pharmapacks publicly listed?No, Pharmapacks is a private, VC-backed company.
What is Pharmapacks' valuation?Pharmapacks was last valued at $1.1B in its undisclosed-stage round in November 2020.
How much funding has Pharmapacks raised?Pharmapacks has raised $473M across 4 funding rounds.
What was Pharmapacks' last funding round?Pharmapacks' last funding round was a $250M undisclosed-stage round in November 2020, led by Carlyle Group.
Who are Pharmapacks' investors?Pharmapacks' investors include Reckitt Benckiser, McKesson Ventures, The Emerson Group, Sealed Air, Sawaya Partners, Carlyle Group, JPMorgan Chase, GPI Capital, The Craftory and The Straus Group.
What is Pharmapacks' revenue?Pharmapacks' latest recorded revenue is $250M (November 2020).
What is Pharmapacks' revenue multiple?Pharmapacks' latest valuation implies a 4.4x revenue multiple ($1.1B valuation on $250M of revenue).
Which companies are comparable to Pharmapacks?Companies comparable to Pharmapacks include GlobalBees, Brands for Less, Oasis Market, HexClad, Hepsiburada and E-MART.
How many companies has Pharmapacks invested in?Pharmapacks has invested in 1 company, including Amara Organic Foods.
What was Pharmapacks' last investment?In November 2021, Pharmapacks invested in Amara Organic Foods' $12M Series A alongside Eat Well Investment Group, Liquid I.V and Spring St. Group.

See companies similar to Pharmapacks

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial